SMS Pharmaceuticals Ltd
NSE:SMSPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SMS Pharmaceuticals Ltd
Cash Interest Paid
SMS Pharmaceuticals Ltd
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SMS Pharmaceuticals Ltd
NSE:SMSPHARMA
|
Cash Interest Paid
₹198.5m
|
CAGR 3-Years
119%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash Interest Paid
₹4.1B
|
CAGR 3-Years
36%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Cash Interest Paid
₹389.7m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash Interest Paid
₹2.7B
|
CAGR 3-Years
90%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Cash Interest Paid
₹3.1B
|
CAGR 3-Years
28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash Interest Paid
₹2.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
SMS Pharmaceuticals Ltd
Glance View
SMS Pharmaceuticals Ltd. is a holding company, which engages in the research, development and marketing of active pharmaceutical ingredients. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2007-02-25. The firm is engaged in the business of manufacturing active pharma ingredients (API) and their intermediates. The firm's API products include Ranitidine HCL (Form-2) USP / Ph.Eur, Famotidine USP / Ph. Eur / JP, Pantoprazole Sodium Sesquihydrate US/Ph. Eur, Itraconazole USP / Ph.Eur / JP, Lanoconazole USP / JP, Sumatriptan Succinate USP / Ph.Eur/ BP, Sumatriptan Base USP / Ph.Eur/ BP, Almotriptan Malate, Zolmitriptan, Rizatriptan Benzoate USP/ Ph.Eur, Eletriptan Hydrobromide Monohydrate, Sildenafil Citrate USP / Ph.Eur, Tadalafil USP / Ph.Eur, Vardenafil and others. The firm's manufacturing facilities are located in Bachupally, Hyderabad in the state of Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram district in Andhra Pradesh. Its research and development (R&D) center is located in Gagillapur, Hyderabad.
See Also
What is SMS Pharmaceuticals Ltd's Cash Interest Paid?
Cash Interest Paid
198.5m
INR
Based on the financial report for Dec 31, 2025, SMS Pharmaceuticals Ltd's Cash Interest Paid amounts to 198.5m INR.
What is SMS Pharmaceuticals Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
27%
Over the last year, the Cash Interest Paid growth was 1%. The average annual Cash Interest Paid growth rates for SMS Pharmaceuticals Ltd have been 119% over the past three years , 27% over the past five years .
